Developments in the APA “Ethical Principles of Psychologists and Code of Conduct” for Neuropsychologists

1.5 CE Credit


Presented by:
Stephen Behnke, PhD, JD
Department of Psychiatry
Harvard Medical School

Robert Kinscherff, PhD, JD
Executive Director
Center for Law, Brain & Behavior
Massachusetts General Hospital, and
Professor, Doctoral Clinical Psychology Program
William James College

Julie A. Suhr, Ph.D.
Professor and Director of Clinical Training
Editor, Psychological Assessment
Department of Psychology

This 90-minute webinar will examine in detail the current and draft versions of the American Psychological Association “Ethical Principles of Psychologists and Code of Conduct.” The webinar will review aspects of the current APA Ethics Code most relevant to neuropsychological practice. This brief review will consist of examining the Code’s Overview, General Principles, and Ethical Standards, with primary attention to the Assessment section of the Ethics Code. Second, the webinar will review the process of revising the APA Ethics Code, in preparation for a detailed examination of the draft APA Ethics Code. The webinar will analyze how the draft code differs from the current code and elicit specific comments and suggested edits from webinar participants.  The goal of this highly interactive webinar will be to provide the APA Ethics Code Revision Task Force feedback that is informed by neuropsychological practitioners in anticipation of the next version of the APA Ethics Code.  The webinar will be presented in collaboration with the Society of Clinical Neuropsychology (SCN), Division 40 of APA.

After the webinar, participants will be able to:
1. Describe aspects of the current APA Ethics Code most relevant to neuropsychological practice.
2. Explain the process of revising the APA Ethics Code.
3. Analyze differences between the current and draft APA Ethics Code.
4. Assess changes to the draft APA Ethics Code informed by a neuropsychological perspective.

Target Audience:  Neuropsychologists at all levels of practice, including trainees.

Instructional Level:  Intermediate  

Dr. Behnke is an American psychologist, ethicist, and author. From November 1, 2000 until July 8, 2015, he was the director of the Office of Ethics for the American Psychological Association. Dr. Behnke received an undergraduate degree from Princeton University in Classics, a JD degree from Yale Law School, a PhD in clinical psychology from the University of Michigan, and a Master of Divinity from Harvard Divinity School. In 1996, Dr. Behnke was made chief psychologist of the Day Hospital Unit at the Massachusetts Mental Health Center, a position he held until 1998 when he was named a faculty fellow in Harvard University’s program in Ethics and the Professions. Dr. Behnke then directed a program in research integrity in the Division of Medical Ethics at Harvard Medical School. In November 2000, he assumed the position of director of ethics at the American Psychological Association which he held until July 2015. He currently holds an appointment in the Department of Psychiatry at Harvard Medical School where he instructs psychology trainees in law and ethics. He served as chair, board of directors, of the Saks Institute for Mental Health Law, Policy, and Ethics at the University of Southern California Law School. Dr. Behnke is the lead author of a state-by-state series on mental health law. He consults with religious communities regarding psychological health and spiritual development.

Dr. Kinscherff has held leadership positions in Massachusetts state government and the trial court, as well as teaching, professional service, and policy advisory/development positions that reflect interests at the intersections of law, policy, applied neuroscience, and clinical/forensic behavioral science. His practice areas include juvenile and adult offenders, post-Miller resentencing and parole cases, expert testimony, violence risk assessment and management, law and policy in justice system reforms and gun violence policy, and the impact of adversities, resiliencies, and social determinants in child, adolescent, and young adult development. He has published widely, teaches and consults nationally and internationally, is involved in state and federal legislative advocacy, and provides trial and appellate judicial education on the implications of developmental neuroscience for law and public policy.

Julie Suhr is Professor and Director of Clinical Training in the Department of Psychology at Ohio University. She is a Fellow of both the Society for Neuropsychology and the National Academy of Neuropsychology She currently serves as a Council Representative for Division 40 of the American Psychological Association. She has published over 100 co-authored peer reviewed articles, 3 books, and numerous book chapters in neuropsychological assessment. She is currently the Editor in Chief of Psychological Assessment, Associate Editor of Journal of Clinical and Experimental Neuropsychology, and on the Editorial Board for The Clinical Neuropsychologist

NAN members login and non-members create an account to:



Digital Neuropsychology in Research and Clinical Practice

1.0 CE Credits

 

Naomi Chaytor, Ph.D., ABPP
Board Certified Clinical Neuropsychologist
Associate Professor (with tenure)
Elson S. Floyd College of Medicine






Laura Germine, PhD 
Assistant Professor of Psychiatry, Harvard Medical School
Co-director, Institute for Technology in Psychiatry, McLean Hospital






Despite clear scientific and public health relevance, methods for comprehensive digital neuropsychological assessment outside the traditional lab or clinical setting are limited.  This lack of assessment flexibility became abundantly clear during the covid19 pandemic, when clinicians were unable to conduct face-to-face testing. Reliance on face-to-face assessment methods also limits our ability to fully understand how cognitive performance varies across time and context. This is particularly important, as data increasingly indicate that cognitive variation is an important early marker of brain dysfunction. This workshop will provide an overview of research and clinical applications of remote, self-administered mobile cognitive assessment in real-world settings.  The presenters will provide examples from their recent experience 1) developing and deploying a remote digital neuropsychological assessment platform to clinicians during the covid19 pandemic, and 2) using mobile cognitive assessment in research focused on understanding the real-world effects of transient physiological and psychological states on cognitive variation.  In the first part of the workshop, the development and validation of neuroscience-based self-administered mobile cognitive tests will be described, including both challenges and opportunities. Next, survey data collected from approximately 1000 clinicians (as of 4/2020) using the TestMyBrain Digital Neuropsychology Toolkit during the covid19 pandemic will be presented. Lastly, an overview of study design considerations involved in ecological momentary assessment of cognition, symptom reporting and passive sensor data will be presented from an ongoing project investigating the cognitive effects of short-term fluctuations in blood glucose and psychological state variables (fatigue, stress, affect) in adults with type 1 diabetes.

After the session, participants will be able to:
1. Describe the key steps in mobile test validation.
2. Understand the advantages and limitations of remote self-administered neurocognitive assessment in clinical practice.
3. Explore research applications of integrated remote assessment of physiological states, self-report data and cognitive performance.

Target Audience: Neuropsychologists and trainees
Instructional Level: Intermediate

Naomi Chaytor, Ph.D., ABPP research is focused on the relationship between cognitive performance and real world functioning in adults with chronic medical and neurological conditions. Most recently, her work has centered on the neuropsychology of type 1 diabetes. Current NIH funded projects include the association between blood glucose fluctuations and cognition in adults with type 1 diabetes, and cognitive, quality of life and emotional outcomes associated with use of diabetes technology in adults with type 1 diabetes. Clinically, she worked for over a decade as a clinical neuropsychologist in neurology and rehabilitation medicine departments. 

Laura Germine, Ph.D. research is oriented around understanding cognitive functioning in health and disease, as well as building technology for studying cognition and behavior using the web and mobile devices. She created one of the first online neuropsychological laboratories in 2005, which later became TestMyBrain.org/. Dr. Germine is also founder and President of the Many Brains project – a 501c3 dedicated to open source software development for cognitive science and neuropsychology.    


NAN members login and non-members create an account to:

Ethical Issues in Neuropsychological Rehabilitation Practice and Research

1.5 CE Credit

Presented by:
Russell M. Bauer, Ph.D., ABPP
Preeminence Professor of Clinical & Health Psychology and Neurology
University of Florida

Although many neuropsychologists attempt to avoid ethical dilemmas at all costs, encountering ethical issues is to be expected in the competent practice of neuropsychology. This presentation will focus on key ethical issues faced by neuropsychologists in rehabilitation practice and research settings. I will address issues related to protecting the welfare of rehabilitation research participants including assignment to active and ‘placebo’ arms of rehabilitation trials, the selection and measurement of appropriate outcomes, informed consent in decisionally impaired patients, and decisions to terminate participation in research. From a practice perspective, issues related to matching patients to appropriate treatments, managing disruptive or harmful behavior, and addressing conflicts arising between the patient and family members affected by neuropsychological disability. The presentation will begin by introducing a framework for ethical decision-making, and the major topical areas described above will be illustrated with hypothetical case scenarios. Using an interactive format, participants will be encouraged to consider and assess the efficacy of alternative resolutions to ethical challenges.

Learning Objectives
After the session, participants will be able to:
1. Identify key ethical issues confronting the neuropsychologist in rehabilitation research and practice settings.
2. Articulate a viable model for identifying, analyzing, implementing, and evaluating potential solutions to ethical problems encountered in the rehabilitation setting.
3. Offer solutions to commonly-encountered ethical problems using a model-driven approach to ethical decision-making

 

Target Audience: Neuropsychologists and trainees
Instructional Level: Intermediate

Russell M. Bauer, Ph.D. is Preeminence Professor of Clinical & Health Psychology and Neurology at the University of Florida Academic Health Center in Gainesville, FL, where he also is Director of the Brain Rehabilitation Research Center of Excellence (BRRC) at the Malcom Randall Veterans Affairs Medical Center. He has served as President of the Society for Clinical Neuropsychology (APA Division 40) and the International Neuropsychological Society. He is Board Certified in Clinical Neuropsychology by the American Board of Clinical Neuropsychology/ABPP, and has served on the ABCN’s oral examination cadre for over 10 years. Dr. Bauer’s clinical work takes place in a patient-centric interdisciplinary TBI clinic in which neurology, neuropsychology, occupational therapists and physical therapists collaborate to develop diagnosis and management plans for persons with complicated recoveries after concussion/TBI. His research program uses novel neurocognitive probes along with structural and functional MRI to develop early markers of neurocognitive decline in aging and TBI. He also studies risk and injury factors that predispose to complicated recovery or chronic symptoms after concussion/mild TBI.

NAN members login and non-members create an account to:



Filling a Huge Void and Expanding Your Practice: Feasible and Practical Neuropsychological Rehabilitation

2.0 CE Credit

Presented by:
Lance Trexler, PhD, FACRM
Executive Director
Brain Injury Rehabilitation Research and Program Development
Rehabilitation Hospital of Indiana




Jill Winegardner, Ph.D.
Director of Neuropsychological Rehabilitation
University Hospitals Cleveland Medical Center

This course is for clinical neuropsychologists who want to offer more than just assessment to their patients. A model to guide rehabilitation that starts with assessment, formulation, and goal setting; incorporates current evidence and follows international guidelines; sees rehabilitation as both art and science; and ends with outcome evaluation will be presented. We will provide practical and clinically useful information on interventions including enhanced feedback, psychoeducation, evidence-based cognitive and mood strategies, and more comprehensive rehabilitation. All recommendations will be theoretically driven and evidence-based, and billing information will be discussed. Clinical examples will be used to illustrate the model and techniques that we describe. You will receive access to resources that will allow you to develop and build your rehabilitation skills in order to confidently offer more comprehensive care in your clinical service.

Learning Objectives
After the session, participants will be able to:
1. Implement a clinical model of neuropsychological rehabilitation.
2. Describe the evidence base for neuropsychological rehabilitation.
3. Deliver enhanced feedback, psychoeducation, and cognitive and mood strategies as part of their clinical practice.
4. Evaluate the outcomes of their rehabilitation care.

Target Audience: Neuropsychologists and trainees
Instructional Level: Intermediate

Lance Trexler, PhD, FACRM is the Executive Director of Brain Injury Rehabilitation Research and Program Development at the Rehabilitation Hospital of Indiana, Adjunct Clinical Assistant Professor of PM&R at the Indiana University School of Medicine, Adjunct Assistant Professor of Speech and Hearing Sciences at Indiana University, and Adjunct Assistant Professor of Psychological Sciences at Purdue University. Dr. Trexler was designated as a Fellow of the American Congress of Rehabilitation Medicine (ACRM) in 2013, and he received the Distinguished Member award in 2015 and the Lifetime Achievement Award in 2019 from ACRM. In addition to serving as a clinician in rehabilitation neuropsychology since 1979, his over-riding commitment as a neuropsychologist has been to develop, implement and disseminate rehabilitation and social interventions for those with acquired brain injury. Dr. Trexler is an author on over fifty peer-reviewed journal articles and book chapters.

Dr. Winegardner is a clinical neuropsychologist and Director of Neuropsychological Rehabilitation at University Hospitals Cleveland Medical Center. From 2010-2018, she was Lead Psychologist at the world-renowned Oliver Zangwill Centre for Neuropsychological Rehabilitation in England. She has provided teaching and consultation in neuropsychological rehabilitation in countries including Turkey, Lebanon, Iran, Russia, India, and Singapore. She is widely published, including co-editing Neuropsychological Rehabilitation: The International Handbook. In 2015, Dr. Winegardner was honored by the British Psychological Society with the Practitioner of the Year Award.

NAN members login and non-members create an account to:



Integration of Clinical Neuropsychology into Primary Care

1.5 CE Credit


Presented by:
Robert Fallows, PsyD, ABPP 
Medical Director – Behavioral Health & Neuropsychology | Samaritan Medical Group









Margaret Lanca, Ph.D.
Director of Adult Neuropsychology and Psychological Testing and Training, Cambridge Health Alliance
Assistant Professor of Psychology, Department of Psychiatry, Harvard Medical School







Psychologists have been integrating into primary care settings for several decades now, with demonstrated benefit for patient access, improving health outcomes, and reducing overall cost of care. Although neuropsychology is not new to the concept of integration (involvement with departments of neurology/neurosurgery, sports medicine, etc.), our presence in primary care is novel. Continued efforts to engage primary care providers will be crucial in both rural and urban areas of the country, especially considering that primary care providers are typically among the top five referral sources for neuropsychologists. This webinar will review some key points related to operating within primary care, including understanding different levels of integration, models for operating a neuropsychology practice in primary care, and outcomes from attempts at integration. Discussion about similarities and differences between urban and rural practice will occur alongside a review of how COVID has impacted primary care integration and what it may mean for integration moving forward.

After the webinar, participants will be able to:
1. Define differences between integrated care and co-location of services and discuss some of the barriers and benefits of both approaches.
2. Describe a tiered approach to care, from curbside consultations to screening services up through full evaluation with intervention.
3. Identify some of the benefits of integration into primary care, including potential for improved referral completion rate and productivity.

Target Audience:  Neuropsychologists, Primary Care Physicians and Behavioral Health Consultants, Health Care Administrators, Psychology and Medical trainees of all levels

Instructional level:  Intermediate


NAN members login and non-members create an account to:



Motivating the Masses: Promoting Brain Health Through Media Work and Public Education

1.5 CE Credit

 

Michelle Braun, Ph.D., ABPP-CN
Ascension Healthcare
Racine, WI






There are many exciting opportunities for neuropsychologists to enhance the health and well-being of the population by sharing our expertise about brain health through public education and media work. Although most neuropsychologists have not been trained to engage with the media, there are a growing number of resources available through professional associations, organizations, and courses to support media exposure and training. During this workshop, you will learn tips to communicate effectively and inspire audiences on radio and television and in print media, podcasts, blogs, social media, and books. We will also discuss the benefits of cultivating community and organizational partnerships, strategies for establishing yourself as an expert, the importance of developing a “platform” to grow your audience (especially if you are interested in writing a book for the public!), and the need to translate your passion for brain health into a unique message. By sharing the importance of brain health directly with the public, we can enhance the health of the population AND increase awareness of the value of neuropsychology!

After the session, participants will be able to:
1. List three strategies to become engaged in public education about brain health and describe how to become involved in media work.
2. Discuss the resources available to support neuropsychologists who wish to become involved in public education and media work. 
3. Describe tips to communicate effectively and inspire audiences.

Target Audience: Neuropsychologists and trainees
Instructional Level: Intermediate

Dr. Michelle Braun is passionate about empowering individuals to boost brain health and reduce the risk of Alzheimer's with science-backed strategies. She has been featured on PBS, Fox Morning News, CBS, iHeart radio, and in other national media outlets. Dr. Braun completed her internship at Yale University School of Medicine, and postdoctoral fellowship at Harvard Medical School/Boston VA after earning her doctoral degree in Clinical Psychology and minor in Neuroscience from the University of Wisconsin-Milwaukee. She previously served as the Assistant Director of Inpatient Mental Health at the Boston VA and Instructor of Psychiatry at Harvard Medical School. Dr. Braun has a popular column on brain health in Psychology Today, and she had a general audience book on brain health published this spring (High-Octane Brain: 5 Science-Based Steps to Sharpen Your Memory and Reduce Your Risk of Alzheimer’s). She  has been an invited speaker for the Alzheimer’s Association for the past 14 years.

NAN members login and non-members create an account to:

Neuroimaging for Neuropsychologists

1.5 CE Credits

Presented by:
Erin Bigler, Ph.D.
 
Some form of brain imaging is routinely performed on most patients that are seen by neuropsychologists.  Neuroimaging is considered a foundation area of study and training for neuropsychologists. This webinar will cover the common neuroimaging modalities of computed tomography (CT), magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT) and positron emission tomography (PET) and their relevance to clinical neuropsychology. The basis for understanding neuroimaging begins with neuroanatomy and neuropathology, which will be covered.  Anatomical identification across the different imaging modalities will be overviewed followed by a very practical approach showing how neuroimaging findings may be integrated with neuropsychological assessment. Neuroimaging findings in common disorders as seen by neuropsychologists such as traumatic brain injury, stroke, multiple sclerosis, neurodevelopmental disorders, aging and neurodegenerative disease will be highlighted. Methods of quantitative neuroimaging, especially automated techniques like FreeSurfer will be overviewed. The webinar will conclude with a discussion of the role of advanced neuroimaging techniques like functional MRI (fMRI) and the development of standardized cognitive probes, use of fMRI techniques in assessing resting state functional connectivity mapping combined with diffusion tensor imaging (DTI) that permit assessment of network functioning in neuropsychology.

After the webinar, participants will be able to:

  1. Describe the differences in technology that generate computed tomographic (CT) scans, magnetic resonance imaging (MRI) scans and radiotracer-based tomography [single photon emission computed tomography  (SPECT) or positron emission tomography (PET).
  2. Assess basic neuroanatomy from viewing CT, MRI, SPECT and/or PET imaging studies.
  3. Explain the basics of neuropathological findings from viewing CT, MRI, SPECT and/or PET imaging studies.
  4. Apply neuroimaging decision making skills relevant to integrating scan findings with neuropsychological assessment and cognitive/neurobehavioral outcome in disorders like traumatic brain injury, stroke, demyelinating disorders, developmental syndromes, ageing and degenerative diseases. 

Target Audience:Clinical neuropsychologists or Ph.D. students in training

Instructional Level:(Intermediate-to-Advanced) The presentation will assume some formal prior training in neuroanatomy and pathoanatomical correlates for the major neurological and neuropsychiatric disorders

About Erin Bigler, Ph.D.
Erin D. Bigler, Ph.D. holds the Susa Young Gates Chair as Professor of Psychology and Neuroscience at Brigham Young University (BYU) where he served as Chair of the Psychology Department for over six years (1996-2002). He is also an Adjunct Professor in the Department of Psychiatry at the University of Utah. He was formerly a professor of psychology and psychiatry at the University of Texas, until he returned to Utah in 1990 to assume his current position. In 1977 at the University of Texas at Austin he established the clinical neuropsychology subspecialty training program that continues to this day and in the early 1980’s at Austin also established the Brain Imaging and Behavior Laboratory, which he brought with him when he came to BYU. The Brain Imaging and Behavior Laboratory has played a key role in numerous multisite collaborative studies providing quantitative neuroimaging analysis. His research has focused on the interface between neuroimaging findings and methods of analysis in the study of cognitive and neurobehavioral outcome associated with a variety of disorders including traumatic brain injury, Alzheimer’s disease and related neurodegenerative disorders and neurodevelopmental disorders like autism and learning disability.  He served as President of the National Academy of Neuropsychology from 1989-1990 and later in 1999, received their Distinguished Clinical Neuropsychologist Award. In that same year, he was also the recipient of the Karl G. Maeser Distinguished Faculty Lecturer Award, Brigham Young University's top faculty honor.

Dr. Bigler has authored and developed several neuropsychological tests, published 90 book chapters, and authored and/or edited 9 textbooks—most recently as one of the coauthors of Muriel Lezak’s Neuropsychological Assessment – 5th  Edition.  He has also authored/co-authored and published over 270 peer-reviewed articles in neuropsychology, neuroimaging and cognitive neuroscience. 

Currently, Dr. Bigler is the President of the International Neuropsychological Society (INS) where he previously served as Treasurer and a member of the Board of Directors for many years. He was the inaugural Associate Editor for the Journal of the International Neuropsychological Society (JINS) and served in that capacity for 11 years.  He is the founding Associate Editor of the journal Brain Imaging and Behavior and likewise serves as an Associate Editor for Neuropsychology along with several other editorial boards.  He has been a licensed psychologist since 1975, practicing in the area of clinical neuropsychology, and holds a Diplomate from the American Board of Professional Psychology with special competence in clinical neuropsychology. He has trained over 125 doctoral students in his nearly 40 years as a professor.  Recently, Dr. Bigler was appointed the Director of BYU’s new MRI Research Facility which houses an on-campus Siemens 3Tesla magnetic resonance scanner.

NAN members login and non-members create an account to:

 

Providing Effective Competency Based Supervision in Clinical Neuropsychology

1.5 CE Credit


Presented by:
Steven Douglas Bodin, Ph.D., ABPP

Supervision is an essential professional activity provided by clinical neuropsychologists. Clinical supervision is now considered a specific competency by the American Psychological Association (APA) and APA has specified guidelines for supervision in health service psychology (APA, 2015). Unfortunately, most practicing neuropsychologists receive very little training in the provision of supervision (Shultz, Pederson, Roper, & Rey-Casserly, 2014). The existing literature on supervision in clinical psychology pertains mostly to therapy supervision. Over the past decade, there has been an increase in attention paid to supervision in neuropsychology (Schultz et al., 2014 and Stucky, Bush, & Donders, 2010). This workshop is designed to provide a review of practical, ethical, legal, and theoretical considerations when providing supervision in clinical neuropsychology from a competency-based approach. 


After the session, participants will be able to:

1. Discuss different models of conducting clinical supervision
2. Apply a competency-based approach to supervision
3. Utilize various techniques and tools to conduct effective supervision


Target Audience: This workshop is intended for practicing neuropsychologists who provide supervision and for advanced trainees who are learning how to conduct clinical supervision.

Instructional Level: Intermediate

Doug Bodin, Ph.D., ABPP is a pediatric neuropsychologist and director of postdoctoral training at Nationwide Children's Hospital. He is also an associate professor of clinical pediatrics at The Ohio State University College of Medicine. Dr. Bodin is board certified in clinical neuropsychology through the American Board of Professional Psychology (ABPP)/American Board of Clinical Neuropsychology (ABCN) with subspecialty board certification in pediatric neuropsychology. Dr. Bodin is a past president of the Association of Post-doctoral Programs in Clinical Neuropsychology (APPCN) and is current president of the American Board of Clinical Neuropsychology (ABCN). Dr. Bodin is on the editorial boards for Archives of Clinical Neuropsychology, Child Neuropsychology, and the Journal of Pediatric Psychology. 

NAN members login and non-members create an account to:



Providing Effective Neuropsychological Supervision

1.5 CE Credits

Presented by:
Bernice Marcopulos, Ph.D.
Associate Professor
Department of Graduate Psychology
James Madison University

As clinical neuropsychologists, many, if not most of us regularly supervise trainees, but do we really know what we are doing? Supervision is seldom taught in graduate school and according to Stucky, Bush & Donders (2010) “it is the extremely rare neuropsychology conference that offers a continuing education workshop on neuropsychological supervision.” (p. 741).  This workshop is intended to address this deficiency and provide an opportunity to reflect upon what makes a good clinical neuropsychology supervisor. This workshop will draw on material from Stucky, et al. (2010) and Fouad et al (2009) to provide a conceptual and structural framework for providing effective supervision in clinical neuropsychology. Participants will review methods for developing and measuring training goals from a developmental perspective (practicum, internship, post-doctoral fellowship). 

After the webinar, participants will be able to:

  1. Utilize foundational and functional competencies in professional psychology as a basis for supervision of trainees in clinical neuropsychology.
  2. List achievable goals of supervision for each level of training (practicum, internship, post-doctoral fellowship) in neuropsychology
  3. Explain how the APA Ethics code and organizational guidelines (NAN, AACN) relate to clinical supervision in neuropsychology
  4. Describe methods for measuring training goals and efficacy of supervision. 

Target Audience:Clinical neuropsychologists involved in supervising practicum students, pre-doctoral interns and postdoctoral fellows in patient care settings

Instructional Level:(Intermediate-to-Advanced) Intermediate

About Bernice A. Marcopulos, Ph.D., ABPP 
Bernice A. Marcopulos, Ph.D., ABPP received her B.A. (High Honors) from the University of Florida and her Ph.D. from the University of Victoria in British Columbia, Canada.  She is Board Certified in Clinical Neuropsychology from the American Board of Professional Psychology. Currently she is Associate Professor of Graduate Psychology at James Madison University in Harrisonburg, VA and Associate Professor of Psychiatry and Neurobehavioral Sciences at the University of Virginia (UVA) Health Sciences Center in Charlottesville, VA. Dr. Marcopulos was the Director of the Western State Hospital (WSH) Neuropsychology Laboratory in Staunton, Virginia for 20 years where she co-Directed (with Drs. Jeff Barth and Donna Broshek) the UVA/WSH post-doctoral fellowship in Clinical Neuropsychology, an Association of Post-Doctoral Programs in Clinical Neuropsychology member program.  She taught assessment in the Department of Psychology at UVA and supervised interns, practicum students and post-doctoral fellows. Her research and clinical interests include the effects of education and culture on neuropsychological testing, dementia, schizophrenia, and criminal forensic issues. She is the co-editor of Clinical Neuropsychological Foundations of Schizophrenia (2012).  She was a Fulbright Fellow in the Psychology Department at the University of Warsaw in 1994 and was elected as a Fellow in NAN and APA. She was recently on the APA Committee for Psychological Tests and Assessment and is a consulting editor for The Clinical Neuropsychologist. She has served as a Board Member and Oral Examiner for the American Board of Clinical Neuropsychology, and she currently chairs the Examination Committee of the ABCN.  Dr. Marcopulos is serving her second term as Secretary of the International Neuropsychological Society.

NAN members login and non-members create an account to:

Securing Neuropsychology’s Future: Make it More Innovative, Relational and Creative

1.5 CE Credits

Presented by:
Karen D. Sullivan, PhD, ABPP
Pinehurst Neuropsychology Brain & Memory Clinic;
I CARE FOR YOUR BRAIN with Dr. Sullivan; and
Medical Chief, The Center for Provider Wellbeing, Foundation of FirstHealth

The future of neuropsychology is threatened by a payor model that increasingly rewards brevity and a trend toward “computerization” that promises diagnostic clarity from a machine, resulting in low interpersonal connection with patients and their families. These pressures could result in a fundamental change in the way neuropsychological services are delivered, jeopardizing our signature comprehensive and interpersonal assessment approach to patient care. In this webinar, the presenter will argue that what must be protected in our evaluation process is the therapeutic alliance we offer as clinical psychologists with expertise in brain/behavior relationships. By intentionally fostering the relational aspects of our work through the guideposts of interpersonal warmth, empathy, and empowerment, we can increase our effectiveness at every point in the evaluation process. Finally, by increasing the innovation of our practice we can safeguard against burnout and satisfy our own desire for a dynamic, creative professional life.

After the webinar, participants will be able to:
1. List the three core relational goals that should be fostered in every neuropsychological evaluation
2. Design an evaluation approach that develops and builds a therapeutic alliance in the interview, testing, and feedback sessions
3. Apply strategies to increase the creativity and innovation of your practice with a specific focus on feedback recommendations

Target Audience:  Neuropsychologists at all levels of practice, including trainees.
Instructional Level:  Intermediate-Advanced 

Karen D. Sullivan, PhD, ABPP, is the creator of the award-winning I CARE FOR YOUR BRAIN education program, owner of a private practice, Pinehurst Neuropsychology Brain & Memory Clinic, and Medical Chief for the Center for Provider Wellbeing at the Foundation of FirstHealth. She received her doctoral degree at Boston University and completed her internship and post-doctoral fellowship in Clinical Neuropsychology at the VA Boston Healthcare System. In 2022, Dr. Sullivan graduated from the Goldman Sachs National 10,000 Small Business entrepreneurial program. Prior to her formal education, she worked as caregiver, nursing assistant, therapeutic companion, activities director and co-director of an Adult Day Health program.


NAN members login and non-members create an account to:

 

 

State of the Long COVID Science: Neuropsychological Assessment, Treatment, and Clinical Considerations Across the Lifespan

1.5 CE Credit

 

Presented by:
Rowena Ng, Ph.D.
Assistant Professor
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Pediatric Neuropsychologist, Department of Neuropsychology
Kennedy Krieger Institute

Tracy D. Vannorsdall, Ph.D.
Associate Professor
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine



 

SARS-CoV-2 infection is associated with post-acute cognitive changes as well as psychological symptoms (e.g., depression, anxiety) that can have significant consequences for patient functioning and quality of life. This webinar will discuss the various definitions of “Long-COVID” or post-acute sequelae of COVID-19 (PASC) as well as the potential biological, psychological, and social mechanisms associated with the persistence of symptoms beyond the acute phase of illness. An updated overview of the scientific literature on neuropsychological outcomes and recovery in PASC will be provided, with specific discussion surrounding pediatric and geriatric populations. Methodological limitations and areas in need of further study will be highlighted. Using case vignettes, we will discuss potential tools for assessing subjective and objective cognitive concerns as well as mental health symptoms in patients across the lifespan. We will conclude with a discussion of potential neuropsychological interventions and treatment recommendations.

After the webinar, participants will be able to:
1. Describe PASC and potential underlying mechanisms. 
2. List neuropsychological tools to assess patients with PASC. 
3. Discuss clinical recommendations and intervention approaches for patients with PASC. 
4. Describe future clinical and research directions involving PASC.

Target Audience: Clinical neuropsychology professionals and students/trainees, and others in related fields (e.g., researchers, physicians, nurses, social workers).

Instructional Level: Introductory - Intermediate

Tracy D. Vannorsdall, Ph.D. is a board-certified clinical neuropsychologist and an Associate Professor within the Department of Psychiatry and Behavioral Sciences and the Department of Neurology at the Johns Hopkins University School of Medicine. She completed her doctoral degree in psychology at the University of Maryland Baltimore County in 2006 following a one-year internship in clinical neuropsychology at the Ann Arbor VA Medical Center. Dr. Vannorsdall then completed a three-year clinical and research fellowship at the Johns Hopkins Department of Psychiatry and Behavioral Sciences. She joined the faculty in 2009 and is currently the Director of Clinical Training in the Division of Medical Psychology. 

Rowena Ng, Ph.D. received a doctoral degree in Clinical Psychology at the University of Minnesota, Twin Cities, where she also served as an undergraduate course instructor in child and adolescent psychology. She completed an internship with an emphasis in pediatric neuropsychology at the UCLA Semel Institute for Neuroscience and Human Behavior, and a fellowship in clinical neuropsychology with lifespan training at the University of Michigan – VA Ann Arbor Postdoctoral Training Consortium. Her research interests include investigating social-affective and cognitive development associated with genetic and neurological disorders, and characterizing risk and resilience factors among adolescents with complex medical conditions. Dr. Ng joined the Department of Neuropsychology at Kennedy Krieger Institute as a pediatric neuropsychologist in 2019, and is an Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine. Dr. Ng is a licensed psychologist in Maryland and provides assessment services for children and adolescents with neurogenetic conditions, seizure disorders, and/or neuropsychiatric conditions.


NAN members login and non-members create an account to:



1.75 CE Credit

 

Presented by:
Kenneth Podell, Ph.D., FACPN
John M. O’Quinn Centennial Clinical Academic Scholar in Concussion Research and Care
Director, The Houston Methodist Concussion Center & Neuropsychology Section








 

C. Munro Cullum, Ph.D., ABPP-CN
The University of Texas Southwestern Medical Center








Gerard A Gioia, PhD
Division Chief, Pediatric Neuropsychology, Children’s National Medical Center

 





The practice of neuropsychology has traditionally been conducted in an office, clinic, or hospital setting with the patient/client present. New models of service are being introduced that open new doors to our profession. Telehealth is revolutionizing health care and becoming a mainstream mode of clinical delivery. Telehealth has the unique ability to connect healthcare providers with patients across town as well as around the world, decrease cost and expand access to high-quality specialty care, and improve patient compliance and satisfaction.  The goal of this panel discussion is to introduce several neuropsychological applications of telehealth. The panel will present and discuss: the history of telehealth in psychology and neuropsychology (aka “telepsychology”); the current technology available for clinical practice; the evidence to support test administration via videoconference in cognitive disorders of aging and sports neuropsychology settings; specifics about state and national laws and insurance and billing issues; and its potential role and limitations in home-based assessments.

 After the webinar, participants will be able to:

1. Outline the history and definition of telepsychology and discuss its clinical and research applications.
2. Describe state laws governing the use of telepsychology in clinical practice along with PSYPACT, Medicare regulations, and ethical guidelines for its use.
3. Discuss the literature and identify reliable and valid measures for video conference-administered assessment.
4. Describe home-based cognitive assessment and discuss its potential to facilitate care as well as its dangers and limitations.

 

Target Audience: Clinicians who are interested in the practical, ethical, and legal considerations when broaching online therapy and assessment services.

Instructional Level: Introductory 

Dr. Podell is the John M. O’Quinn Centennial Clinical Academic Scholar in Concussion Research and Care and the Director of The Houston Methodist Concussion Center and Neuropsychology Section, Dept. of Neurology, Houston Methodist. and is an Associate Professor in Neurology at Weill-Cornell Medical College, Institute of Academic Medicine, Houston Methodist, and Texas A&M College of Medicine and an Adjunct Associate Professor of Psychology, University of Houston. He is a Fellow of The National Academy of Neuropsychology and Sports Neuropsychology Society. He has lectured extensively on various aspects of sports-concussion assessment and treatment.  He has been involved tele-health delivery for concussion assessment care for over four years.

Dr. Cullum is Professor of Psychiatry, Neurology, and Neurological Surgery at The University of Texas Southwestern Medical Center.  He holds the Pam Blumenthal Distinguished Professorship in Clinical Psychology, serves as Vice Chair and Chief of the Division of Psychology in the Department of Psychiatry, and is the Senior Neuropsychologist in the Peter O’Donnell Brain Institute at UT Southwestern.  He completed his PhD in Clinical Psychology at The University of Texas at Austin, followed by an internship and postdoctoral residency in clinical neuropsychology at UCSD and the San Diego VA.  Dr. Cullum’s research includes short and long term effects of concussion as well as risk factors and differential diagnosis of neurodegenerative conditions, as well as neuropsychological applications of telehealth technology.  He is the Scientific Director for the Texas Alzheimer’s Research and Care Consortium (TARCC), is a Past-President of the National Academy of Neuropsychology and the Society for Clinical Neuropsychology (APA Division 40), and is President-Elect of the Sports Neuropsychology Society.  

Dr. Gioia is the Division Chief of Pediatric Neuropsychology at Children’s National Health System, where he directs the SCORE Concussion Program. He is Professor of Pediatrics and Psychiatry at the GWU School of Medicine. He has developed a number of post-concussion tools for children, and worked with the CDC on their “Heads Up” concussion educational toolkits. Dr. Gioia has participated in the International Concussion in Sport Group Consensus meetings, American Academy of Neurology Sports Concussion Guideline panel, and the CDC’s mild TBI guideline development. He provided concussion management services to youth, high school, college and professional teams. He is the current President and Fellow of the Sports Neuropsychology Society.

NAN members login and non-members create an account to:




Update on Health Care Policy: From Status to Advocacy

1.0 CE Credit

 

Presented by:

Antonio E. Puente, Ph.D.
Professor of Psychology
University of North Carolina Wilmington




 Despite a languishing congressional legislative climate, numerous legal and regulatory changes have occurred in 2018-2019 resulting in considerable paradigm shifts in the conceptualization and delivery of neuropsychological services. The foundational concepts will be presented as a means to understanding the reason for the majority of these changes. Pragmatic applications of these foundational concepts will then be described as a means to understand how the practice of neuropsychology is changing. A comparison of traditional and new models for the practice of clinical neuropsychology will be discussed. Limitations to this paradigm shift will be considered, with potential solutions outlined. Finally, the horizon of anticipated changes will be presented as a means to begin preparing for the new round of health care shifts.

 After the webinar, participants will be able to:

1. Describe the history and foundation for the practice of clinical neuropsychology.
2. Explain the basic reasons why the new testing codes occurred.
3. Discuss how the present situation is a paradigm shift not only for reimbursement but for the practice of clinical neuropsychology.

Target Audience: Psychologists interested in receiving updated information regarding APA reorganization, advocacy efforts, and changes to CPT codes. 

Instructional Level: Introductory

Antonio Puente, Ph.D., Professor of Psychology at the University of North Carolina Wilmington (UNCW), was the 2017 President of the American Psychological Association.  His research focuses on the interface between culture and neuropsychology and is the author/editor of eight books, 22 chapters, and 110 articles. He maintains a private practice in clinical neuropsychology, ranging from clinical to forensic assessments.  He was on the Editorial Panel of the American Medical Association’s Current Procedural Terminology.

NAN members login and non-members create an account to:



Wada (Intracarotid Amobarbital) Procedure: Clinical Applications 

1.5 CE Credits

Presented by:
Gregory P. Lee, Ph.D., ABPP-CN
Professor, Department of Neurology, School of Medicine
Professor, School of Allied Health Sciences and School of Graduate Studies
Georgia Health Sciences University

Wada testing is an established method to lateralize language and memory functions prior to epilepsy surgery in an attempt to prevent postoperative aphasia and memory loss.  Wada memory testing has also become useful in corroborating the side of seizure onset and assisting in the prediction of seizure-relief outcome.  This webinar will describe in detail the current most widely utilized Wada testing protocol for assessing language and memory after amobarbital administration as well as the related angiography procedures and how to analyze results and make surgical recommendations.  Discussion regarding potential confounding factors, such as angiographic cross-flow, fetal origin arteries, antiepileptic drugs that may reduce amobarbital potency, seizures during the procedure, and severe behavioral reactions will be reviewed.  The pros and cons of using drugs other than amobarbital will be briefly considered and the status of the Wada in light of the newer, less invasive procedures, such as functional MRI and magnetoencephalography will also be covered.  

After the webinar, participants will be able to:

  1. Describe the cognitive testing methods used to evaluate language and memory during the Wada procedure.
  2. Analyze common Wada test result patterns and apply them to surgical recommendations.
  3. List the major problems than can arise during the Wada and select procedures that help reduce their impact.
  4. List the medical diagnostic procedures that will most likely replace Wada testing eventually and describe their current shortcomings.  

Target Audience: Clinical neuropsychologists and students of neuropsychology (residents, interns, graduate students) who are interested in epilepsy surgery practice.

Instructional Level: Intermediate-to-Advanced

About Gregory P. Lee, Ph.D., ABPP-CN 
Dr. Lee is a Professor of Neurology in the Medical College of Georgia at Georgia Regents University.  He is board-certified in Clinical Neuropsychology by ABPP/ABCN and a fellow of the American Psychological Association and the National Academy of Neuropsychology.  Dr. Lee is the Director of Adult Neuropsychological Services for the Departments of Neurology and Neurosurgery at the Medical College of Georgia, and he teaches courses in the behavioral neurosciences for medical, allied health, and neuroscience graduate students and neurology residents.  Professor Lee is also an active researcher with over 150 publications primarily in the areas of clinical epilepsy and epilepsy surgery, and author of the book, Neuropsychology of Epilepsy & Epilepsy Surgery, published by Oxford University Press.

NAN members login and non-members create an account to:

 

Writing Useful Neuropsychological Reports

2.0 CE Credit

 

Presented by:

Jacobus Donders, PhD, ABPP
Chief Psychologist
Mary Free Bed Rehabilitation Hospital




 





This seminar describes ways to improve the degree to which reports on neuropsychological assessments are useful to the consumer, whether that be a physician, a parent, a teacher, a judge, or another party.  Examples of application across the lifespan and in both clinical and forensic settings are provided.  Special attention is paid to the training of interns and residents in report writing, and how constructive supervision may make this process more effective.  

After the webinar, participants will be able to:
1. Discuss general guidelines for preparation of evidence-based and practically useful neuropsychological reports.
2. Apply specific guidelines for effective report writing in various clinical and forensic settings across the lifespan.
3. Use a Socratic method of supervision to help predoctoral and postdoctoral trainees develop better report writing skills.

Target Audience: Clinical and forensic neuropsychologists and neuropsychology trainees

Instructional Level: Intermediate

Dr. Jacobus Donders is the Chief Psychologist at Mary Free Bed Rehabilitation Hospital in Grand Rapids, MI.  He is board-certified in Clinical Neuropsychology as well as Rehabilitation Psychology through the American Board of Professional Psychology.  In addition to being an active clinical practitioner, he has served on multiple editorial and executive boards, has authored or co-authored more than 100 publications in peer-reviewed journals, and has edited or co-edited six textbooks.  Dr. Donders is a current associate editor of the journals Child Neuropsychology and Archives of Clinical Neuropsychology.  He is completing his term as secretary of the American Board of Clinical Neuropsychology.  He is also a Fellow of the American Psychological Association and of the National Academy of Neuropsychology.

NAN members login and non-members create an account to: